These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 27979574)

  • 41. Apelin/APJ system: A novel promising target for neurodegenerative diseases.
    Luo H; Han L; Xu J
    J Cell Physiol; 2020 Feb; 235(2):638-657. PubMed ID: 31254280
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Cardioprotective effect of electroacupuncture in cardiopulmonary bypass through apelin/APJ signaling.
    Wang K; Ju Z; Chen C; Fan S; Pei L; Feng C; Wang F; Cui H; Zhou J
    Life Sci; 2020 Feb; 242():117208. PubMed ID: 31870773
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Therapeutic potential of apelin and Elabela in cardiovascular disease.
    Gao S; Chen H
    Biomed Pharmacother; 2023 Oct; 166():115268. PubMed ID: 37562237
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The Apelin-APJ axis alleviates LPS-induced pulmonary fibrosis and endothelial mesenchymal transformation in mice by promoting Angiotensin-Converting Enzyme 2.
    Wang H; Cong L; Yin X; Zhang N; Zhu M; Sun T; Fan J; Xue F; Fan X; Gong Y
    Cell Signal; 2022 Oct; 98():110418. PubMed ID: 35882286
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Downregulation of the Apelinergic Axis Accelerates Aging, whereas Its Systemic Restoration Improves the Mammalian Healthspan.
    Rai R; Ghosh AK; Eren M; Mackie AR; Levine DC; Kim SY; Cedernaes J; Ramirez V; Procissi D; Smith LH; Woodruff TK; Bass J; Vaughan DE
    Cell Rep; 2017 Nov; 21(6):1471-1480. PubMed ID: 29117554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Apelin/APJ system in inflammation.
    Wang X; Zhang L; Li P; Zheng Y; Yang Y; Ji S
    Int Immunopharmacol; 2022 Aug; 109():108822. PubMed ID: 35605524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The therapeutic potentials of apelin in obesity-associated diseases.
    Castan-Laurell I; Dray C; Valet P
    Mol Cell Endocrinol; 2021 Jun; 529():111278. PubMed ID: 33838166
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The biological function of ELABELA and APJ signaling in the cardiovascular system and pre-eclampsia.
    Liu Y; Wang L; Shi H
    Hypertens Res; 2019 Jul; 42(7):928-934. PubMed ID: 30626933
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Apelin and apelin receptor at different stages of corpus luteum development and effect of apelin on progesterone secretion and 3β-hydroxysteroid dehydrogenase (3β-HSD) in pigs.
    Różycka M; Kurowska P; Grzesiak M; Kotula-Balak M; Tworzydło W; Rame C; Gregoraszczuk E; Dupont J; Rak A
    Anim Reprod Sci; 2018 May; 192():251-260. PubMed ID: 29576467
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Individual phosphorylation sites at the C-terminus of the apelin receptor play different roles in signal transduction.
    Chen J; Chen X; Li S; Jiang Y; Mao H; Zhang R; Ji B; Yan M; Cai X; Wang C
    Redox Biol; 2020 Sep; 36():101629. PubMed ID: 32863206
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apelin/APJ system: a promising therapy target for hypertension.
    Wu D; He L; Chen L
    Mol Biol Rep; 2014 Oct; 41(10):6691-703. PubMed ID: 24990699
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting drugs to APJ receptor: From signaling to pathophysiological effects.
    Huang Z; He L; Chen Z; Chen L
    J Cell Physiol; 2018 Jan; 234(1):61-74. PubMed ID: 30070701
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular effects of apelin: Mechanisms and therapeutic potential.
    Mughal A; O'Rourke ST
    Pharmacol Ther; 2018 Oct; 190():139-147. PubMed ID: 29807055
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Xiaoyaosan Improves Depressive-Like Behaviors in Mice through Regulating Apelin-APJ System in Hypothalamus.
    Yan Z; Jiao H; Ding X; Ma Q; Li X; Pan Q; Wang T; Hou Y; Jiang Y; Liu Y; Chen J
    Molecules; 2018 May; 23(5):. PubMed ID: 29751542
    [No Abstract]   [Full Text] [Related]  

  • 55. Apelin/APJ system: A novel therapeutic target for oxidative stress-related inflammatory diseases (Review).
    Zhou Q; Cao J; Chen L
    Int J Mol Med; 2016 May; 37(5):1159-69. PubMed ID: 27035220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuroprotective gain of Apelin/APJ system.
    Zhou JX; Shuai NN; Wang B; Jin X; Kuang X; Tian SW
    Neuropeptides; 2021 Jun; 87():102131. PubMed ID: 33640616
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apelin/APJ signaling in hypoxia-related diseases.
    He L; Xu J; Chen L; Li L
    Clin Chim Acta; 2015 Dec; 451(Pt B):191-8. PubMed ID: 26436483
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Central apelin administration and restraint stress induce hypothalamic cholecystokinin release via the APJ receptor.
    Bülbül M; Sinen O; Abueid L; Akkoyunlu G; Özsoy Ö
    J Neuroendocrinol; 2018 Sep; 30(9):e12635. PubMed ID: 30044523
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The microRNA-204-5p inhibits APJ signalling and confers resistance to cardiac hypertrophy and dysfunction.
    Gaddam RR; Kim YR; Jacobs JS; Yoon JY; Li Q; Cai A; Shankaiahgari H; London B; Irani K; Vikram A
    Clin Transl Med; 2022 Jan; 12(1):e693. PubMed ID: 35060347
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of serine 348 on the apelin receptor as a novel regulatory phosphorylation site in apelin-13-induced G protein-independent biased signaling.
    Chen X; Bai B; Tian Y; Du H; Chen J
    J Biol Chem; 2014 Nov; 289(45):31173-87. PubMed ID: 25271156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.